155 related articles for article (PubMed ID: 20205748)
1. The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophages.
Brodsky M; Halpert G; Albeck M; Sredni B
J Inflamm (Lond); 2010 Jan; 7(1):3. PubMed ID: 20205748
[TBL] [Abstract][Full Text] [Related]
2. The effect of the novel tellurium compound AS101 on autoimmune diseases.
Halpert G; Sredni B
Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulating tellurium compounds as anti-cancer agents.
Sredni B
Semin Cancer Biol; 2012 Feb; 22(1):60-9. PubMed ID: 22202556
[TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury.
Brodsky M; Hirsh S; Albeck M; Sredni B
J Hepatol; 2009 Sep; 51(3):491-503. PubMed ID: 19595469
[TBL] [Abstract][Full Text] [Related]
5. The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium.
Ling D; Liu B; Jawad S; Thompson IA; Nagineni CN; Dailey J; Chien J; Sredni B; Nussenblatt RB
Br J Ophthalmol; 2013 Jul; 97(7):934-8. PubMed ID: 23624272
[TBL] [Abstract][Full Text] [Related]
6. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
Brodsky M; Yosef S; Galit R; Albeck M; Longo DL; Albeck A; Sredni B
J Interferon Cytokine Res; 2007 Jun; 27(6):453-62. PubMed ID: 17572009
[TBL] [Abstract][Full Text] [Related]
7. The Small Tellurium Compound AS101 Ameliorates Rat Crescentic Glomerulonephritis: Association with Inhibition of Macrophage Caspase-1 Activity
Hachmo Y; Kalechman Y; Skornick I; Gafter U; Caspi RR; Sredni B
Front Immunol; 2017; 8():240. PubMed ID: 28326083
[TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice.
Gross M; Stanciu E; Kenigsbuch-Sredni D; Sredni B; Pinhasov A
Behav Pharmacol; 2017 Sep; 28(6):458-465. PubMed ID: 28590303
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
Kalechman Y; Sredni B
J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
[TBL] [Abstract][Full Text] [Related]
10. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
Okun E; Dikshtein Y; Carmely A; Saida H; Frei G; Sela BA; Varshavsky L; Ofir A; Levy E; Albeck M; Sredni B
FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
[TBL] [Abstract][Full Text] [Related]
11. Tellurium Compounds Prevent and Reverse Type-1 Diabetes in NOD Mice by Modulating α4β7 Integrin Activity, IL-1β, and T Regulatory Cells.
Yossipof TE; Bazak ZR; Kenigsbuch-Sredni D; Caspi RR; Kalechman Y; Sredni B
Front Immunol; 2019; 10():979. PubMed ID: 31191514
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models.
Sredni B; Geffen-Aricha R; Duan W; Albeck M; Shalit F; Lander HM; Kinor N; Sagi O; Albeck A; Yosef S; Brodsky M; Sredni-Kenigsbuch D; Sonino T; Longo DL; Mattson MP; Yadid G
FASEB J; 2007 Jun; 21(8):1870-83. PubMed ID: 17314138
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a better understanding of its medicinal properties.
Chiaverini L; Tolbatov I; Marrone A; Marzo T; Biver T; La Mendola D
J Inorg Biochem; 2024 Jul; 256():112567. PubMed ID: 38669911
[TBL] [Abstract][Full Text] [Related]
14. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
Sredni B; Weil M; Khomenok G; Lebenthal I; Teitz S; Mardor Y; Ram Z; Orenstein A; Kershenovich A; Michowiz S; Cohen YI; Rappaport ZH; Freidkin I; Albeck M; Longo DL; Kalechman Y
Cancer Res; 2004 Mar; 64(5):1843-52. PubMed ID: 14996748
[TBL] [Abstract][Full Text] [Related]
15. Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101.
Frei GM; Kremer M; Hanschmann KM; Krause S; Albeck M; Sredni B; Schnierle BS
Br J Dermatol; 2008 Mar; 158(3):578-86. PubMed ID: 18241275
[TBL] [Abstract][Full Text] [Related]
16. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
Sredni B; Gal R; Cohen IJ; Dazard JE; Givol D; Gafter U; Motro B; Eliyahu S; Albeck M; Lander HM; Kalechman Y
FASEB J; 2004 Feb; 18(2):400-2. PubMed ID: 14656992
[TBL] [Abstract][Full Text] [Related]
17. Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.
Chiaverini L; Cirri D; Tolbatov I; Corsi F; Piano I; Marrone A; Pratesi A; Marzo T; La Mendola D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886853
[TBL] [Abstract][Full Text] [Related]
18.
Yang TY; Tseng SP; Ho HC; Chen LH; Hsueh PR; Lu PL; Lin CH; Wang LC
Microbiol Spectr; 2023 Mar; 11(2):e0149622. PubMed ID: 36877078
[TBL] [Abstract][Full Text] [Related]
19. The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes.
Halperin-Sheinfeld M; Gertler A; Okun E; Sredni B; Cohen HY
Aging (Albany NY); 2012 Jun; 4(6):436-47. PubMed ID: 22761194
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
